Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

130.28 -2.38 (-1.79%)
Official Closing Price Updated: 7:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,770,993
Open 132.29
Bid (Size) 130.00 (1)
Ask (Size) 130.15 (1)
Prev. Close 132.66
Today's Range 129.44 - 132.61
52wk Range 99.71 - 141.23
Shares Outstanding 1,750,942,289
Dividend Yield 1.69%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
3 Reasons to Avoid ABT and 1 Stock to Buy Instead
Abbott Laboratories’s 16.6% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $136.50 per share. This run-up might have investors contemplating their... 
Via StockStory
Topics Stocks
Exposures US Equities

Performance

YTD
+14.84%
+14.84%
1 Month
-0.78%
-0.78%
3 Month
+14.14%
+14.14%
6 Month
+11.73%
+11.73%
1 Year
+7.88%
+7.88%

More News

Read More
Recent Report Shows That Sen. Shelley M Capito Sold Up to $75K Worth of Comcast Stock
Via Benzinga
Florida Rep. Jared Moskowitz Sold Up to $15K Worth of West Pharmaceutical Servs Stock
Via Benzinga
2 Dependable Dividend Stocks That Can Pay You for Life
Via The Motley Fool
Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Where Abbott Laboratories Stands With Analysts
Via Benzinga
What Does the Market Think About Abbott Laboratories?
Via Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
Via Benzinga
Indications Suggest ABBOTT LABORATORIES (NYSE:ABT) Could Be on the Verge of a Breakout.
Via Chartmill
3 Reasons ABBV is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
Exposures US Equities
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
Via StockStory
Q4 Earnings Roundup: Baxter (NYSE:BAX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Via StockStory
Biotech Stocks Stay Strong Through A Period Of Uncertainty In The Market
Via Talk Markets
Topics ETFs Stocks / Equities
Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
Via StockStory
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
Via Benzinga
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
Rep. Emily Randall Has Sold Up to $165K Worth Of Abbott Laboratories Stock: Here's What You Should Know
Via Benzinga
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
Via The Motley Fool
Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)
Via StockStory
3 Fabulous Dividend Stocks to Buy in February
Via The Motley Fool
3 Dividend Growth Stocks For Intergenerational Wealth
Via Talk Markets
Topics Stocks / Equities
2 Unstoppable Dividend Stocks That Will Pay You for Life
Via The Motley Fool
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars
Via StockStory
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates
Via StockStory
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.